Keyphrases
Opioid Antagonist
100%
CXCL10
100%
Neuroinflammation
100%
Sickness Behavior
100%
Chemokine (C-C motif) Ligand 2 (CCL2)
100%
Lipopolysaccharide-induced
100%
Interleukin-6
50%
Infectious Diseases
16%
Neurodegenerative Diseases
16%
Adult Male
16%
Chemokine Expression
16%
Chemokines
16%
Lipopolysaccharide
16%
Interferon-inducible Protein 10
16%
Inflammatory Pathways
16%
Neuroprotective Effect
16%
Etiology
16%
Traumatic Brain Injury
16%
Open Field Test
16%
Distance Moved
16%
Anti-inflammatory Effect
16%
Mood Disorders
16%
Monocyte Chemoattractant protein-1 (MCP-1)
16%
β-funaltrexamine
16%
Behavior Analysis
16%
Inflammatory Cytokines
16%
Anxiety-like Behavior
16%
Reduced Expression
16%
Bacterial Lipopolysaccharide
16%
Brain Pathology
16%
Economic Burden
16%
Human Astrocytes
16%
C57BL
16%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Neuroscience
Lipopolysaccharide
100%
CXCL10
100%
CCL2
100%
Sickness Behavior
100%
Narcotic Antagonist
100%
Blood Plasma
66%
Interleukin 6
50%
Chemokine
33%
Neurodegenerative Disorder
16%
In Vivo
16%
In Vitro
16%
Astrocyte
16%
Gamma Interferon Inducible Protein 10
16%
Behavior (Neuroscience)
16%
Mood Disorder
16%
Monocyte Chemotactic Protein 1
16%
Neurotrauma
16%
Neuroprotective Agent
16%
Bacterium Lipopolysaccharide
16%
Proinflammatory Cytokine
16%
Anti-Inflammatory
16%
Traumatic Brain Injury
16%